C Vogel
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 2
- Bone health and treatments 1
- Cancer-related Molecular Pathways 1
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Eric P. Winer (2 shared papers)John Hohneker (1 shared paper)Mark Allen O’Rourke (1 shared paper)Simon A. Jones (1 shared paper)BC Lembersky (1 shared paper)Joseph Bigley (1 shared paper)Laura F. Hutchins (1 shared paper)Leslie R. Laufman (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)European Journal of Cancer (1 paper)Breast Cancer Research (1 paper)Annals of Oncology (1 paper)Ultraschall in der Medizin - European Journal of Ultrasound (1 paper)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
C Vogel
8 papers receiving 314 citations
Peers
Comparison fields: 5 of 40
- Oncology 302
- Cancer Research 128
- Dermatology 35
- Radiology, Nuclear Medicine and Imaging 67
- Genetics 24
Countries citing papers authored by C Vogel
This map shows the geographic impact of C Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Vogel more than expected).
Fields of papers citing papers by C Vogel
This network shows the impact of papers produced by C Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Vogel. The network helps show where C Vogel may publish in the future.
Co-authors
The 25 scholars most cited alongside C Vogel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 159 | |
| 2 | 1999 | 88 | |
| 3 | First line, non-hormonal treatment of women with HER2 overexpressing metastatic breast cancer with herceptin (trastuzumab, humanized anti-HER2 antibody) | 2000 | 44 |
| 4 | 2009 | 20 | |
| 5 | 2014 | 10 | |
| 6 | 2001 | 6 | |
| 7 | 1995 | 3 | |
| 8 | 2024 | 2 |
About C Vogel
C Vogel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Infectious Diseases, having authored 8 papers that have together received 332 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers), Antimicrobial Resistance in Staphylococcus (1 paper), Bone health and treatments (1 paper), Cancer-related Molecular Pathways (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Oncology (302 citations), Cancer Research (128 citations), Dermatology (35 citations), Radiology, Nuclear Medicine and Imaging (67 citations) and Genetics (24 citations). C Vogel has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Eric P. Winer, John Hohneker, Mark Allen O’Rourke, Simon A. Jones, BC Lembersky, Joseph Bigley, Laura F. Hutchins, Leslie R. Laufman, Daniel R. Budman and M OROURKE. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research, Annals of Oncology and Ultraschall in der Medizin - European Journal of Ultrasound.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.